Quarter Period Consolidated Statement Of Comprehensive Income

Daito Pharmaceutical Co., Ltd. - Filing #7611167

Concept 2021-06-01 to
2022-02-28
2020-06-01 to
2021-02-28
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
3,948,811,000 JPY
3,683,079,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
41,243,000 JPY
-203,436,000 JPY
Foreign currency translation adjustment
74,989,000 JPY
42,246,000 JPY
Remeasurements of defined benefit plans, net of tax
4,740,000 JPY
23,076,000 JPY
Other comprehensive income
120,972,000 JPY
-138,114,000 JPY
Comprehensive income
4,069,784,000 JPY
3,544,965,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
4,077,744,000 JPY
3,548,991,000 JPY
Comprehensive income attributable to non-controlling interests
-7,960,000 JPY
-4,026,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.